Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Focus on Europe

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 6 December 1991:
Vol. 254. no. 5037, pp. 1507 - 1509
DOI: 10.1126/science.1962212
Prev | Table of Contents | Next

Articles

Science, Vol 254, Issue 5037, 1507-1509
Copyright © 1991 by American Association for the Advancement of Science

articles

Systemic delivery of recombinant proteins by genetically modified myoblasts

E Barr and JM Leiden

Howard Hughes Medical Institute, University of Michigan Medical Center, Ann Arbor 48109.

The ability to stably deliver recombinant proteins to the systemic circulation would facilitate the treatment of a variety of acquired and inherited diseases. To explore the feasibility of the use of genetically engineered myoblasts as a recombinant protein delivery system, stable transfectants of the murine C2C12 myoblast cell line were produced that synthesize and secrete high levels of human growth hormone (hGH) in vitro. Mice injected with hGH-transfected myoblasts had significant levels of hGH in both muscle and serum that were stable for at least 3 weeks after injection. Histological examination of muscles injected with beta-galactosidase-expressing C2C12 myoblasts demonstrated that many of the injected cells had fused to form multinucleated myotubes. Thus, genetically engineered myoblasts can be used for the stable delivery of recombinant proteins into the circulation.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors.
A. Sacco, R. Doyonnas, M. A. LaBarge, M. M. Hammer, P. Kraft, and H. M. Blau (2005)
J. Cell Biol. 171, 483-492
   Abstract »    Full Text »    PDF »
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.
M. Hayase, F. del Monte, Y. Kawase, B. D. MacNeill, J. McGregor, R. Yoneyama, K. Hoshino, T. Tsuji, A. M. De Grand, J. K. Gwathmey, et al. (2005)
Am J Physiol Heart Circ Physiol 288, H2995-H3000
   Abstract »    Full Text »    PDF »
Gene Therapy for Central Diabetes Insipidus: Effective Antidiuresis by Muscle-Targeted Gene Transfer.
M. Yoshida, Y. Iwasaki, M. Asai, T. Nigawara, and Y. Oiso (2004)
Endocrinology 145, 261-268
   Abstract »    Full Text »    PDF »
Gene Therapy in Orthopaedic Surgery.
D. Hannallah, B. Peterson, J. R. Lieberman, F. H. Fu, and J. Huard (2002)
J. Bone Joint Surg. Am. 84, 1046-1061
   Full Text »
Gene and Stem Cell Therapies.
E. H. Kaji and J. M. Leiden (2001)
JAMA 285, 545-550
   Abstract »    Full Text »    PDF »
VEGF Gene Delivery to Myocardium : Deleterious Effects of Unregulated Expression.
R. J. Lee, M. L. Springer, W. E. Blanco-Bose, R. Shaw, P. C. Ursell, and H. M. Blau (2000)
Circulation 102, 898-901
   Abstract »    Full Text »    PDF »
Cell Transplantation as Future Therapy for Cardiovascular Disease? : A Workshop of the National Heart, Lung, and Blood Institute.
L. Reinlib and L. Field (2000)
Circulation 101 , e182-e187
   Abstract »    Full Text »    PDF »
Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer.
A. K. Malik, P. E. Monahan, D. L. Allen, B.-G. Chen, R. J. Samulski, and K. Kurachi (2000)
J. Virol. 74, 3555-3565
   Abstract »    Full Text »
Lovastatin Inhibits Transforming Growth Factor-{beta}1 Expression in Diabetic Rat Glomeruli and Cultured Rat Mesangial Cells.
S. IL KIM, D. C. HAN, and H. B. LEE (2000)
J. Am. Soc. Nephrol. 11, 80-87
   Abstract »    Full Text »
Autologous heart cell transplantation improves cardiac function after myocardial injury.
T. Sakai, R.-K. Li, R. D. Weisel, D. A.G. Mickle, E.-J. Kim, S. Tomita, Z.-Q. Jia, and T. M. Yau (1999)
Ann. Thorac. Surg. 68, 2074-2080
   Abstract »    Full Text »    PDF »
The Effect of Regional Gene Therapy with Bone Morphogenetic Protein-2-Producing Bone-Marrow Cells on the Repair of Segmental Femoral Defects in Rats.
J. R. LIEBERMAN, A. DALUISKI, S. STEVENSON, L. JOLLA, L. WU, P. McALLISTER, Y. P. LEE, J. M. KABO, G. A.M. FINERMAN, A. J. BERK, et al. (1999)
J. Bone Joint Surg. Am. 81, 905-17
   Abstract »    Full Text »
Dynamics of Myoblast Transplantation Reveal a Discrete Minority of Precursors with Stem Cell-like Properties as the Myogenic Source.
J. R. Beauchamp, J. E. Morgan, C. N. Pagel, and T. A. Partridge (1999)
J. Cell Biol. 144, 1113-1122
   Abstract »    Full Text »    PDF »
Prolonged Reduction of High Blood Pressure With Human Nitric Oxide Synthase Gene Delivery.
K.-F. Lin, L. Chao, and J. Chao (1997)
Hypertension 30, 307-313
   Abstract »    Full Text »
TRANSPLANTATION OF GENETICALLY MARKED CARDIAC MUSCLE CELLS.
S. Gojo, S. Kitamura, O. Hatano, A. Takakusu, K. Hashimoto, Y. Kanegae, and I. Saito (1997)
J. Thorac. Cardiovasc. Surg. 113, 10-18
   Abstract »    Full Text »
Angiogenic Gene Therapy: A Leg to Stand On?.
J. C. Fox and J. L. Swain (1996)
Circulation 94, 3065-3066
   Full Text »
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.
P. D. Kessler, G. M. Podsakoff, X. Chen, S. A. McQuiston, P. C. Colosi, L. A. Matelis, G. J. Kurtzman, and B. J. Byrne (1996)
PNAS 93, 14082-14087
   Abstract »    Full Text »    PDF »
Transport pathway, maturation, and targetting of the vesicular stomatitis virus glycoprotein in skeletal muscle fibers.
P Rahkila, A Alakangas, K Vaananen, and K Metsikko (1996)
J. Cell Sci. 109, 1585-1596
   Abstract »    PDF »
Muscle-Mediated Gene Therapy.
H. M. Blau and M. L. Springer (1995)
N. Engl. J. Med. 333, 1554-1556
   Full Text »    PDF »
Human Atrial Natriuretic Peptide Gene Delivery Reduces Blood Pressure in Hypertensive Rats.
K.-F. Lin, J. Chao, and L. Chao (1995)
Hypertension 26, 847-853
   Abstract »    Full Text »
Gene Therapy for Cardiovascular Disease.
E. G. Nabel (1995)
Circulation 91, 541-548
   Full Text »
Intramuscular Delivery of Rat Kallikrein-binding Protein Gene Reverses Hypotension in Transgenic Mice Expressing Human Tissue Kallikrein.
J.-x. Ma, Z. Yang, J. Chao, and L. Chao (1995)
J. Biol. Chem. 270, 451-455
   Abstract »    Full Text »    PDF »
Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor.
E. Filvaroff, R Ebner, and R Derynck (1994)
Development 120, 1085-1095
   Abstract »    PDF »
The basic science of gene therapy.
R. Mulligan (1993)
Science 260, 926-932
   Abstract »    PDF »
Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells.
S. Yao and K Kurachi (1993)
J. Cell Sci. 105, 957-963
   Abstract »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)